Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001383010 | SCV001582015 | pathogenic | Familial hemophagocytic lymphohistiocytosis 3 | 2023-10-26 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 12 of the UNC13D gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in UNC13D are known to be pathogenic (PMID: 14622600). This variant is present in population databases (rs754205110, gnomAD 0.006%). Disruption of this splice site has been observed in individuals with familial hemophagocytic lymphohistiocytosis (PMID: 23180437, 29262924). ClinVar contains an entry for this variant (Variation ID: 1070748). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV001383010 | SCV002020814 | pathogenic | Familial hemophagocytic lymphohistiocytosis 3 | 2019-12-20 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002264288 | SCV002543122 | pathogenic | Autoinflammatory syndrome | 2019-09-01 | criteria provided, single submitter | clinical testing | |
Diagnostic Genetics, |
RCV001383010 | SCV003837573 | likely pathogenic | Familial hemophagocytic lymphohistiocytosis 3 | 2023-01-03 | criteria provided, single submitter | clinical testing |